Unilife Corporation (UNIS) 0.68 $UNIS
Unilife Realigns Business Units and Leadership Team
PR Newswire - Mon Mar 14, 7:09AM CDT
Unilife Corporation (NASDAQ: UNIS, ASX: UNS), a developer and supplier of injectable drug delivery systems, today announced the realignment of its business units and leadership team to efficiently focus operations on the revenue-generating programs of key strategic customers.
UNIS: 0.68 (+0.02)
Unilife reports 2Q loss
Automated Insights - Tue Feb 09, 6:23PM CST
YORK, Pa. (AP) _ Unilife Corp. (UNIS) on Tuesday reported a loss of $25.4 million in its fiscal second quarter.
UNIS: 0.68 (+0.02)
Unilife Corporation Announces Financial Results For the Second Quarter of Fiscal Year 2016
PR Newswire - Tue Feb 09, 3:49PM CST
Unilife Corporation ("Unilife" or "Company"
(NASDAQ: UNIS; ASX: UNS), a developer and supplier of injectable drug delivery systems, today announced its financial results for the second quarter of fiscal 2016 (three months ended December 31, 2015).
UNIS: 0.68 (+0.02)
Global Prefilled Syringes Market Size Growth of 12.9% CAGR by 2020 - Analysis, Technologies & Forecast Report 2016-2020 - Key Vendors: Baxter International Inc, Becton Dickinson & Bespak Europe
M2 - Thu Feb 04, 10:03AM CST
Research and Markets (http://www.researchandmarkets.com/research/6tvbnq/global_prefilled) has announced the addition of the "Global Prefilled Syringes Market Size, Share, Development, Growth and Demand Forecast to 2020 - Industry Insights by Type (Glass Prefilled Syringe, Plastic Prefilled Syringe)" report to their offering. The global prefilled syringes market accounted for $3,905.1 million value in 2014, and it is expected to grow with a CAGR of 12.9% during 2015-2020. Among the various types, the glass prefilled syringes segment dominated the global prefilled syringes market, with 90.1% share in 2014. Report Coverage: - Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis - Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market - Uncovers potential demands in the market - Porter analysis identifies competitive forces within the market - Provides information on the historical and current market size and the future potential of the market - Provides sizes of key regional markets using yardsticks of processes, segments, products, end user and technology, etc (as applicable) - Provides profiles of major competitors of the market including details of their operations, product and services, recent developments and key financial metrics. Profiles provide better understanding of competition as well as the demands of the market Companies Mentioned: - Baxter International Inc. - Becton Dickinson and Company - Bespak Europe Ltd. - Gerresheimer AG - Medtronic PLC. - Nipro Corporation - SCHOTT AG - Stevanato Group S.p.a. - Unilife Corporation - Vetter Pharma-Fertigung GmbH& Co. KG - Weigao Group - West Pharmaceutical Services Inc. - Ypsomed Holding AG Report Structure: 1. Research Scope and Methodology 2. Executive Summary 3. Market Outlook 4. Global Prefilled Syringes Market Size and Forecast (2014 - 2020) 6. Global Prefilled Syringes Market Breakdown by Geography 7. Competitive Analysis 8. Company Profiles and Strategic Developments 9. Appendix For more information visit http://www.researchandmarkets.com/research/6t..._prefilled
WST: 69.32 (+0.86), UNIS: 0.68 (+0.02), MDT: 75.00 (-0.42), BAX: 41.08 (-0.18)
Unilife Corporation (UNIS) in Focus: Stock Soars 20.7%
Zacks Equity Research - Zacks Investment Research - Tue Jan 26, 7:30AM CST
Unilife Corporation (UNIS) was a big mover last session, as the company saw its shares rise roughly 21% on the day.
CAPR: 2.54 (+0.01), UNIS: 0.68 (+0.02)
10 Best-Performing Small-Cap Stocks in 2016
at The Street - Sat Jan 23, 1:40PM CST
Small-cap stocks are taking a beating this month due to market volatility, but there are outliers in the group. Here are the 10 best-performing Russell 2000 stocks this month.
ZFGN: 6.68 (+0.37), UNIS: 0.68 (+0.02), PLCE: 83.47 (+0.61), RMR: 25.01 (-0.03), RSE: 18.38 (+0.08), BURL: 56.24 (+0.77), VHC: 4.59 (-0.11), AFFX: 14.01 (+0.02), SIEN: 6.84 (-0.01), NLS: 19.32 (+0.32)
Global Prefilled Syringes Market Analysis & Trends - Poised to Grow at a CAGR of Around 12.8% in the Next 5 Years to Reach Approximately $5.3 Billion by 2020
M2 - Thu Jan 14, 4:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/2m8d34/global_prefilled) has announced the addition of the "Global Prefilled Syringes Market Analysis & Trends - Industry Forecast to 2020" report to their offering. The Global Prefilled Syringes Market is poised to grow at a CAGR of around 12.8% in the next 5 years to reach approximately $5.3 billion by 2020. This industry report analyzes the global markets for Prefilled Syringes across all the given segments in the research scope. It presents historical market data for 2012, 2013, 2014 revenue estimations are presented for 2015 and forecasts till 2020. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report provides comprehensive market analysis across four major geographies such as North America, Europe, Asia Pacific and Other parts of the world. Report Highlights: - The report provides a detailed analysis with current and future market trends to identify the investment opportunities - Market forecasts till 2020, using estimated market values as the base numbers - Key market trends across the business segments, Regions and countries - Key developments and strategies observed in the market - In-depth company profiles of key players and upcoming prominent players - Market opportunities and recommendations for new investments Key Topics Covered: 1 Market Outline 2 Executive Summary 3 Market Overview 4 By Syringe type 5 By Design of syringe 6 By Therapeutic areas 7 By Application 8 By Geography 9 Leading Companies - Baxter International, Inc. - Becton, Dickinson & Co. - Bespak - Covidien - Gerresheimer AG - Medtronic PLC. - Nipro Corporation - Schott AG - Stevanato Group - Unilife Corporation - Vetter Pharma International GmbH - Weigao Group - West Pharmaceutical Services, Inc. - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/2m..._prefilled
WST: 69.32 (+0.86), BDX: 151.82 (-0.72), UNIS: 0.68 (+0.02), MDT: 75.00 (-0.42), BAX: 41.08 (-0.18)
BUYINS.NET: UNIS, FSLR, VMBS, NXPI Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Jan 08, 6:43AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Unilife Corp (NASDAQ:UNIS), First Solar Inc (NASDAQ:FSLR), Vanguard Mortgage Backed Securities ETF (NASDAQ:VMBS), NXP Semiconductors NV (NASDAQ:NXPI) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
FSLR: 68.47 (-0.50), UNIS: 0.68 (+0.02), VMBS: 53.47 (+0.07), NXPI: 81.07 (-0.68)
Strength Seen in Unilife (UNIS): Stock Moves 5.1% Higher
Zacks Equity Research - Zacks Investment Research - Thu Jan 07, 7:00AM CST
Unilife (UNIS) was a big mover last session, with its shares rising over 5% on the day.
UNIS: 0.68 (+0.02), ABAX: 45.39 (+1.05)
Unilife Corporation Announces Financial Results For the First Quarter of Fiscal Year 2016
PR Newswire - Mon Nov 09, 7:30AM CST
Unilife Corporation ("Unilife" or "Company" (NASDAQ:UNIS; ASX: UNS), a developer and supplier of injectable drug delivery systems, today announced its financial results for the first quarter of fiscal 2016 (ended September 30, 2015).
UNIS: 0.68 (+0.02), MS: 25.01 (-0.06)
Unilife enters into commercial medical supply agreement with MedImmune
M2 - Thu Nov 05, 5:09AM CST
Drug delivery systems company Unilife (NASDAQ:UNIS)(ASX:UNS) disclosed on Wednesday that it has signed the first supply agreement under its November 2013 Master Development and Supply Agreement (MDSA) with MedImmune, the biologics research and development arm of AstraZeneca.
UNIS: 0.68 (+0.02)
Unilife Signs Commercial Supply Agreement with MedImmune
PR Newswire - Wed Nov 04, 8:00AM CST
Unilife Corporation (NASDAQ:UNIS, ASX: UNS), a U.S. based designer, developer and supplier of injectable drug delivery systems, today announced the signing of the first supply agreement under its November 2013 Master Development and Supply Agreement ("MDSA" with MedImmune, the global biologics research and development arm of AstraZeneca.
UNIS: 0.68 (+0.02)
Unilife Corporation to Announce Financial Results For Fiscal Year 2016 First Quarter on Monday, November 9, 2015
PR Newswire - Mon Oct 26, 7:00AM CDT
Unilife Corporation ("Unilife" or "Company" (NASDAQ: UNIS; ASX: UNS) announced today that it intends to release its financial results for the fiscal 2016 first quarter ended September 30, 2015 after market trading ends on Monday, November 9, 2015.
UNIS: 0.68 (+0.02)
Unilife signs additional financing agreement and cost reduction initiative
M2 - Mon Oct 19, 4:48AM CDT
Drug delivery company Unilife (Nasdaq:UNIS)(ASX:UNS) reported on Friday the launch of an agreement for the provision of up to another USD10m in debt financing from an affiliate of OrbiMed.
UNIS: 0.68 (+0.02)
Unilife Announces Additional Financing of up to $10 Million from OrbiMed and Implements an Additional Cost Reduction Initiative
PR Newswire - Fri Oct 16, 7:30AM CDT
Unilife Corporation ("Unilife" or "Company" (NASDAQ: UNIS, ASX: UNS) today announced the signing of an agreement with an affiliate of OrbiMed for the provision of up to an additional $10 million in debt financing. The material terms are described in a Form 8-K filed by the Company with the SEC today.
UNIS: 0.68 (+0.02), MS: 25.01 (-0.06)
Unilife amends agreement to supply clinical products for use in Novartis' targeted early-stage pipeline drugs
M2 - Fri Sep 25, 5:42AM CDT
Injectable drug delivery company Unilife (NASDAQ:UNIS)(ASX:UNS) announced on Thursday that it has amended its clinical supply agreement to supply clinical products from one of its platforms of injectable drug delivery systems for use with one of Novartis' targeted early-stage pipeline drugs.
UNIS: 0.68 (+0.02), NVS: 72.44 (-0.11)
Unilife Amends Clinical Supply Agreement with Global Pharmaceutical Customer for Delivery of a Novel Drug into a Target Organ of the Body
PR Newswire - Thu Sep 24, 8:00AM CDT
Unilife Corporation ("Unilife" or the "Company" (NASDAQ: UNIS and ASX: UNS), a developer, manufacturer and supplier of injectable drug delivery systems, today announced an amendment to a clinical supply agreement originally signed with Novartis in December 2013 to supply clinical products from one of its platforms of injectable drug delivery systems for use with one of Novartis' targeted early-stage pipeline drugs.
UNIS: 0.68 (+0.02), NVS: 72.44 (-0.11)
Healthcare Sector Equities under Review -- Baxter Intl., Brookdale Senior Living, Envision Healthcare Holdings, Unilife, and Thoratec
PR Newswire - Wed Sep 23, 7:21AM CDT
Equity Research Institute has initiated coverage on the following equities: Baxter International Inc. (NYSE: BAX), Brookdale Senior Living Inc. (NYSE: BKD), Envision Healthcare Holdings Inc. (NYSE: EVHC), Unilife Corporation (NASDAQ: UNIS), and Thoratec Corporation (NASDAQ: THOR). Free research report on Baxter Intl. can be accessed at https://www.erionline.net/BAX.pdf On Tuesday, September 22, 2015, the NASDAQ Composite ended at 4,756.72, down 1.50%, the Dow Jones Industrial Average lost 1.09%, to finish the day at 16,330.47, and the S&P 500 closed at 1,942.74, down 1.23%. The losses were broad based as eight out of nine sectors ended the session in negative. Register for your complimentary reports at the links given below.
UNIS: 0.68 (+0.02), EVHC: 20.40 (-0.07), BAX: 41.08 (-0.18), THOR: 63.50 (+0.05), BKD: 15.88 (+0.46)
Upgrade Alert for Unilife (UNIS)
Comtex SmarTrend(R) - Thu Sep 17, 7:09AM CDT
Unilife (NASDAQ:UNIS) was upgraded from Neutral to Buy at Griffen Securities today. The stock closed yesterday at $1.12 on volume of 1.9 million shares, above average daily volume of 1.5 million. Over the past year, Unilife has traded in a range of $1.10 to $6.04 and closed yesterday at $1.12, 2% above that low. Over the last five market days, the 200-day moving average (MA) has gone down 1% while the 50-day MA has declined 3.1%.
UNIS: 0.68 (+0.02)
Unilife Realigns Business Units and Leadership Team
PR Newswire - Mon Mar 14, 7:09AM CDT
Unilife Corporation (NASDAQ: UNIS, ASX: UNS), a developer and supplier of injectable drug delivery systems, today announced the realignment of its business units and leadership team to efficiently focus operations on the revenue-generating programs of key strategic customers.
UNIS: 0.68 (+0.02)
Unilife reports 2Q loss
Automated Insights - Tue Feb 09, 6:23PM CST
YORK, Pa. (AP) _ Unilife Corp. (UNIS) on Tuesday reported a loss of $25.4 million in its fiscal second quarter.
UNIS: 0.68 (+0.02)
Unilife Corporation Announces Financial Results For the Second Quarter of Fiscal Year 2016
PR Newswire - Tue Feb 09, 3:49PM CST
Unilife Corporation ("Unilife" or "Company"
(NASDAQ: UNIS; ASX: UNS), a developer and supplier of injectable drug delivery systems, today announced its financial results for the second quarter of fiscal 2016 (three months ended December 31, 2015). UNIS: 0.68 (+0.02)
Global Prefilled Syringes Market Size Growth of 12.9% CAGR by 2020 - Analysis, Technologies & Forecast Report 2016-2020 - Key Vendors: Baxter International Inc, Becton Dickinson & Bespak Europe
M2 - Thu Feb 04, 10:03AM CST
Research and Markets (http://www.researchandmarkets.com/research/6tvbnq/global_prefilled) has announced the addition of the "Global Prefilled Syringes Market Size, Share, Development, Growth and Demand Forecast to 2020 - Industry Insights by Type (Glass Prefilled Syringe, Plastic Prefilled Syringe)" report to their offering. The global prefilled syringes market accounted for $3,905.1 million value in 2014, and it is expected to grow with a CAGR of 12.9% during 2015-2020. Among the various types, the glass prefilled syringes segment dominated the global prefilled syringes market, with 90.1% share in 2014. Report Coverage: - Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis - Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market - Uncovers potential demands in the market - Porter analysis identifies competitive forces within the market - Provides information on the historical and current market size and the future potential of the market - Provides sizes of key regional markets using yardsticks of processes, segments, products, end user and technology, etc (as applicable) - Provides profiles of major competitors of the market including details of their operations, product and services, recent developments and key financial metrics. Profiles provide better understanding of competition as well as the demands of the market Companies Mentioned: - Baxter International Inc. - Becton Dickinson and Company - Bespak Europe Ltd. - Gerresheimer AG - Medtronic PLC. - Nipro Corporation - SCHOTT AG - Stevanato Group S.p.a. - Unilife Corporation - Vetter Pharma-Fertigung GmbH& Co. KG - Weigao Group - West Pharmaceutical Services Inc. - Ypsomed Holding AG Report Structure: 1. Research Scope and Methodology 2. Executive Summary 3. Market Outlook 4. Global Prefilled Syringes Market Size and Forecast (2014 - 2020) 6. Global Prefilled Syringes Market Breakdown by Geography 7. Competitive Analysis 8. Company Profiles and Strategic Developments 9. Appendix For more information visit http://www.researchandmarkets.com/research/6t..._prefilled
WST: 69.32 (+0.86), UNIS: 0.68 (+0.02), MDT: 75.00 (-0.42), BAX: 41.08 (-0.18)
Unilife Corporation (UNIS) in Focus: Stock Soars 20.7%
Zacks Equity Research - Zacks Investment Research - Tue Jan 26, 7:30AM CST
Unilife Corporation (UNIS) was a big mover last session, as the company saw its shares rise roughly 21% on the day.
CAPR: 2.54 (+0.01), UNIS: 0.68 (+0.02)
10 Best-Performing Small-Cap Stocks in 2016
at The Street - Sat Jan 23, 1:40PM CST
Small-cap stocks are taking a beating this month due to market volatility, but there are outliers in the group. Here are the 10 best-performing Russell 2000 stocks this month.
ZFGN: 6.68 (+0.37), UNIS: 0.68 (+0.02), PLCE: 83.47 (+0.61), RMR: 25.01 (-0.03), RSE: 18.38 (+0.08), BURL: 56.24 (+0.77), VHC: 4.59 (-0.11), AFFX: 14.01 (+0.02), SIEN: 6.84 (-0.01), NLS: 19.32 (+0.32)
Global Prefilled Syringes Market Analysis & Trends - Poised to Grow at a CAGR of Around 12.8% in the Next 5 Years to Reach Approximately $5.3 Billion by 2020
M2 - Thu Jan 14, 4:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/2m8d34/global_prefilled) has announced the addition of the "Global Prefilled Syringes Market Analysis & Trends - Industry Forecast to 2020" report to their offering. The Global Prefilled Syringes Market is poised to grow at a CAGR of around 12.8% in the next 5 years to reach approximately $5.3 billion by 2020. This industry report analyzes the global markets for Prefilled Syringes across all the given segments in the research scope. It presents historical market data for 2012, 2013, 2014 revenue estimations are presented for 2015 and forecasts till 2020. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report provides comprehensive market analysis across four major geographies such as North America, Europe, Asia Pacific and Other parts of the world. Report Highlights: - The report provides a detailed analysis with current and future market trends to identify the investment opportunities - Market forecasts till 2020, using estimated market values as the base numbers - Key market trends across the business segments, Regions and countries - Key developments and strategies observed in the market - In-depth company profiles of key players and upcoming prominent players - Market opportunities and recommendations for new investments Key Topics Covered: 1 Market Outline 2 Executive Summary 3 Market Overview 4 By Syringe type 5 By Design of syringe 6 By Therapeutic areas 7 By Application 8 By Geography 9 Leading Companies - Baxter International, Inc. - Becton, Dickinson & Co. - Bespak - Covidien - Gerresheimer AG - Medtronic PLC. - Nipro Corporation - Schott AG - Stevanato Group - Unilife Corporation - Vetter Pharma International GmbH - Weigao Group - West Pharmaceutical Services, Inc. - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/2m..._prefilled
WST: 69.32 (+0.86), BDX: 151.82 (-0.72), UNIS: 0.68 (+0.02), MDT: 75.00 (-0.42), BAX: 41.08 (-0.18)
BUYINS.NET: UNIS, FSLR, VMBS, NXPI Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Jan 08, 6:43AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Unilife Corp (NASDAQ:UNIS), First Solar Inc (NASDAQ:FSLR), Vanguard Mortgage Backed Securities ETF (NASDAQ:VMBS), NXP Semiconductors NV (NASDAQ:NXPI) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
FSLR: 68.47 (-0.50), UNIS: 0.68 (+0.02), VMBS: 53.47 (+0.07), NXPI: 81.07 (-0.68)
Strength Seen in Unilife (UNIS): Stock Moves 5.1% Higher
Zacks Equity Research - Zacks Investment Research - Thu Jan 07, 7:00AM CST
Unilife (UNIS) was a big mover last session, with its shares rising over 5% on the day.
UNIS: 0.68 (+0.02), ABAX: 45.39 (+1.05)
Unilife Corporation Announces Financial Results For the First Quarter of Fiscal Year 2016
PR Newswire - Mon Nov 09, 7:30AM CST
Unilife Corporation ("Unilife" or "Company"
(NASDAQ:UNIS; ASX: UNS), a developer and supplier of injectable drug delivery systems, today announced its financial results for the first quarter of fiscal 2016 (ended September 30, 2015). UNIS: 0.68 (+0.02), MS: 25.01 (-0.06)
Unilife enters into commercial medical supply agreement with MedImmune
M2 - Thu Nov 05, 5:09AM CST
Drug delivery systems company Unilife (NASDAQ:UNIS)(ASX:UNS) disclosed on Wednesday that it has signed the first supply agreement under its November 2013 Master Development and Supply Agreement (MDSA) with MedImmune, the biologics research and development arm of AstraZeneca.
UNIS: 0.68 (+0.02)
Unilife Signs Commercial Supply Agreement with MedImmune
PR Newswire - Wed Nov 04, 8:00AM CST
Unilife Corporation (NASDAQ:UNIS, ASX: UNS), a U.S. based designer, developer and supplier of injectable drug delivery systems, today announced the signing of the first supply agreement under its November 2013 Master Development and Supply Agreement ("MDSA"
with MedImmune, the global biologics research and development arm of AstraZeneca. UNIS: 0.68 (+0.02)
Unilife Corporation to Announce Financial Results For Fiscal Year 2016 First Quarter on Monday, November 9, 2015
PR Newswire - Mon Oct 26, 7:00AM CDT
Unilife Corporation ("Unilife" or "Company"
(NASDAQ: UNIS; ASX: UNS) announced today that it intends to release its financial results for the fiscal 2016 first quarter ended September 30, 2015 after market trading ends on Monday, November 9, 2015. UNIS: 0.68 (+0.02)
Unilife signs additional financing agreement and cost reduction initiative
M2 - Mon Oct 19, 4:48AM CDT
Drug delivery company Unilife (Nasdaq:UNIS)(ASX:UNS) reported on Friday the launch of an agreement for the provision of up to another USD10m in debt financing from an affiliate of OrbiMed.
UNIS: 0.68 (+0.02)
Unilife Announces Additional Financing of up to $10 Million from OrbiMed and Implements an Additional Cost Reduction Initiative
PR Newswire - Fri Oct 16, 7:30AM CDT
Unilife Corporation ("Unilife" or "Company"
(NASDAQ: UNIS, ASX: UNS) today announced the signing of an agreement with an affiliate of OrbiMed for the provision of up to an additional $10 million in debt financing. The material terms are described in a Form 8-K filed by the Company with the SEC today. UNIS: 0.68 (+0.02), MS: 25.01 (-0.06)
Unilife amends agreement to supply clinical products for use in Novartis' targeted early-stage pipeline drugs
M2 - Fri Sep 25, 5:42AM CDT
Injectable drug delivery company Unilife (NASDAQ:UNIS)(ASX:UNS) announced on Thursday that it has amended its clinical supply agreement to supply clinical products from one of its platforms of injectable drug delivery systems for use with one of Novartis' targeted early-stage pipeline drugs.
UNIS: 0.68 (+0.02), NVS: 72.44 (-0.11)
Unilife Amends Clinical Supply Agreement with Global Pharmaceutical Customer for Delivery of a Novel Drug into a Target Organ of the Body
PR Newswire - Thu Sep 24, 8:00AM CDT
Unilife Corporation ("Unilife" or the "Company"
(NASDAQ: UNIS and ASX: UNS), a developer, manufacturer and supplier of injectable drug delivery systems, today announced an amendment to a clinical supply agreement originally signed with Novartis in December 2013 to supply clinical products from one of its platforms of injectable drug delivery systems for use with one of Novartis' targeted early-stage pipeline drugs. UNIS: 0.68 (+0.02), NVS: 72.44 (-0.11)
Healthcare Sector Equities under Review -- Baxter Intl., Brookdale Senior Living, Envision Healthcare Holdings, Unilife, and Thoratec
PR Newswire - Wed Sep 23, 7:21AM CDT
Equity Research Institute has initiated coverage on the following equities: Baxter International Inc. (NYSE: BAX), Brookdale Senior Living Inc. (NYSE: BKD), Envision Healthcare Holdings Inc. (NYSE: EVHC), Unilife Corporation (NASDAQ: UNIS), and Thoratec Corporation (NASDAQ: THOR). Free research report on Baxter Intl. can be accessed at https://www.erionline.net/BAX.pdf On Tuesday, September 22, 2015, the NASDAQ Composite ended at 4,756.72, down 1.50%, the Dow Jones Industrial Average lost 1.09%, to finish the day at 16,330.47, and the S&P 500 closed at 1,942.74, down 1.23%. The losses were broad based as eight out of nine sectors ended the session in negative. Register for your complimentary reports at the links given below.
UNIS: 0.68 (+0.02), EVHC: 20.40 (-0.07), BAX: 41.08 (-0.18), THOR: 63.50 (+0.05), BKD: 15.88 (+0.46)
Upgrade Alert for Unilife (UNIS)
Comtex SmarTrend(R) - Thu Sep 17, 7:09AM CDT
Unilife (NASDAQ:UNIS) was upgraded from Neutral to Buy at Griffen Securities today. The stock closed yesterday at $1.12 on volume of 1.9 million shares, above average daily volume of 1.5 million. Over the past year, Unilife has traded in a range of $1.10 to $6.04 and closed yesterday at $1.12, 2% above that low. Over the last five market days, the 200-day moving average (MA) has gone down 1% while the 50-day MA has declined 3.1%.
UNIS: 0.68 (+0.02)
